All News #Library
Rare Diseases
Kye Pharma Licenses SLENYTO from Neurim for Canadian Market
13 Jan 2026 //
PR NEWSWIRE
Health Canada Greenlights Agamree For Duchenne DMD
02 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support